Karyopharm Therapeutics Inc banner

Karyopharm Therapeutics Inc
NASDAQ:KPTI

Watchlist Manager
Karyopharm Therapeutics Inc Logo
Karyopharm Therapeutics Inc
NASDAQ:KPTI
Watchlist
Price: 7.73 USD -7.98% Market Closed
Market Cap: $141.8m

Cash Flow Statement

Cash Flow Statement
Karyopharm Therapeutics Inc

Rotate your device to view
Cash Flow Statement
Currency: USD
Mar-2013 Jun-2013 Sep-2013 Dec-2013 Mar-2014 Jun-2014 Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024 Mar-2025 Jun-2025 Sep-2025 Dec-2025
Operating Cash Flow
Net Income
(22)
(20)
(26)
(34)
(42)
(52)
(62)
(76)
(88)
(104)
(115)
(118)
(119)
(117)
(112)
(110)
(112)
(112)
(117)
(129)
(138)
(142)
(159)
(178)
(206)
(216)
(209)
(200)
(186)
(189)
(202)
(196)
(201)
(208)
(206)
(124)
(108)
(104)
(88)
(165)
(158)
(142)
(140)
(143)
(146)
(90)
(87)
(76)
(63)
(124)
(125)
(196)
Depreciation & Amortization
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
Stock-Based Compensation
1
1
2
4
6
10
12
14
15
16
16
17
18
20
23
22
23
22
21
20
19
18
18
17
17
17
16
15
17
19
22
24
27
28
29
30
30
37
36
35
33
24
23
22
21
21
20
18
17
15
14
14
Other Non-Cash Items
1
1
2
4
7
10
12
14
15
17
18
19
20
22
24
23
24
23
22
22
20
19
18
19
19
20
21
21
23
26
30
34
35
35
41
39
39
45
37
35
32
22
20
18
18
(40)
(42)
(51)
(69)
(8)
3
92
Cash Interest Paid
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5
0
0
0
17
7
11
11
11
Change in Working Capital
(0)
0
(0)
(0)
(0)
(0)
1
10
11
10
10
5
1
4
2
1
2
1
6
33
33
23
24
(0)
(5)
(7)
(12)
(13)
(7)
1
1
1
(3)
(11)
1
(23)
(45)
(35)
(47)
(20)
16
19
19
31
10
(1)
9
(0)
9
28
32
28
Cash from Operating Activities
(21)
N/A
(19)
+8%
(24)
-28%
(30)
-25%
(36)
-18%
(41)
-16%
(49)
-18%
(51)
-6%
(61)
-19%
(77)
-27%
(86)
-12%
(94)
-9%
(97)
-3%
(90)
+7%
(85)
+6%
(84)
+0%
(86)
-2%
(87)
-1%
(88)
-2%
(74)
+16%
(84)
-13%
(100)
-19%
(116)
-17%
(159)
-37%
(191)
-20%
(202)
-6%
(200)
+1%
(191)
+4%
(169)
+11%
(161)
+5%
(169)
-5%
(160)
+5%
(168)
-5%
(184)
-9%
(163)
+11%
(107)
+34%
(113)
-6%
(93)
+18%
(97)
-5%
(150)
-54%
(109)
+27%
(100)
+9%
(101)
-1%
(93)
+8%
(118)
-27%
(130)
-11%
(120)
+8%
(127)
-6%
(123)
+4%
(103)
+16%
(89)
+13%
(75)
+16%
Investing Cash Flow
Capital Expenditures
(0)
(0)
(0)
(0)
(0)
(1)
(3)
(3)
(3)
(3)
(1)
(1)
(1)
(1)
(1)
(0)
0
0
(0)
(0)
(0)
(1)
(1)
(2)
(2)
(2)
(1)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
0
0
(0)
(0)
(0)
(0)
0
0
0
0
Other Items
0
0
0
0
(0)
(0)
(0)
(64)
(234)
(232)
(188)
(89)
87
102
52
25
18
1
27
17
19
(7)
(6)
(105)
(76)
(9)
10
79
0
(100)
(119)
(54)
36
143
143
142
85
2
(8)
(104)
(123)
(65)
(84)
8
62
93
108
96
89
56
53
43
Cash from Investing Activities
(0)
N/A
(0)
+75%
(0)
N/A
(0)
-100%
(1)
-883%
(1)
-54%
(3)
-248%
(67)
-2 015%
(237)
-253%
(235)
+0%
(189)
+20%
(91)
+52%
86
N/A
101
+18%
52
-49%
25
-53%
18
-25%
1
-94%
27
+2 460%
17
-36%
19
+11%
(7)
N/A
(7)
0%
(108)
-1 345%
(78)
+27%
(11)
+86%
9
N/A
78
+785%
(0)
N/A
(100)
-499 150%
(119)
-19%
(54)
+55%
36
N/A
142
+296%
142
N/A
142
0%
85
-40%
2
-98%
(8)
N/A
(104)
-1 173%
(123)
-18%
(65)
+47%
(84)
-30%
8
N/A
62
+684%
92
+48%
108
+16%
95
-11%
89
-7%
56
-37%
53
-5%
43
-18%
Financing Cash Flow
Net Issuance of Common Stock
15
34
75
186
180
157
226
113
204
204
91
93
2
2
33
51
51
103
72
76
76
171
171
149
149
2
17
51
215
217
203
172
18
18
17
14
34
33
39
194
163
163
157
1
0
1
1
1
0
1
1
10
Net Issuance of Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
167
0
0
241
74
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
43
43
43
0
0
0
27
Other
0
0
0
0
0
(0)
0
0
0
0
0
0
0
0
0
(0)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
60
60
60
0
0
0
0
0
0
0
0
0
(3)
(3)
(3)
0
0
0
(6)
Cash from Financing Activities
15
N/A
34
+123%
75
+124%
186
+147%
180
-3%
157
-13%
226
+44%
113
-50%
204
+81%
205
+0%
91
-55%
93
+1%
2
-98%
2
+13%
33
+1 604%
51
+53%
51
0%
103
+103%
72
-30%
76
+5%
76
+0%
171
+124%
171
+0%
316
+85%
316
0%
169
-46%
257
+52%
124
-52%
289
+132%
291
+1%
203
-30%
172
-15%
18
-90%
78
+335%
77
-2%
74
-4%
94
+27%
33
-65%
39
+18%
194
+399%
163
-16%
163
0%
157
-4%
1
-99%
0
N/A
41
N/A
41
N/A
42
+1%
0
N/A
1
N/A
1
N/A
30
+2 800%
Change in Cash
Effect of Foreign Exchange Rates
0
0
0
0
0
0
0
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
0
0
0
0
0
0
(0)
(0)
(0)
(0)
0
(0)
(0)
0
0
0
0
0
(0)
(0)
(0)
(1)
(0)
(0)
(0)
0
(0)
0
0
0
(0)
0
0
(0)
0
Net Change in Cash
(6)
N/A
15
N/A
51
+249%
156
+205%
144
-7%
115
-20%
174
+52%
(5)
N/A
(93)
-1 640%
(108)
-16%
(184)
-70%
(92)
+50%
(9)
+90%
13
N/A
0
-97%
(9)
N/A
(17)
-91%
18
N/A
11
-40%
19
+83%
12
-39%
64
+444%
47
-26%
49
+4%
46
-6%
(43)
N/A
66
N/A
12
-82%
120
+901%
29
-75%
(85)
N/A
(42)
+51%
(114)
-174%
37
N/A
56
+52%
108
+92%
65
-40%
(59)
N/A
(67)
-15%
(61)
+10%
(69)
-15%
(2)
+97%
(28)
-1 200%
(84)
-194%
(54)
+35%
3
N/A
29
+775%
10
-66%
8
-20%
(46)
N/A
(35)
+24%
(2)
+95%
Free Cash Flow
Free Cash Flow
(21)
N/A
(19)
+9%
(24)
-28%
(30)
-25%
(36)
-18%
(42)
-17%
(52)
-23%
(54)
-5%
(64)
-18%
(80)
-26%
(87)
-9%
(95)
-9%
(98)
-3%
(90)
+8%
(85)
+6%
(84)
+1%
(86)
-2%
(87)
-1%
(88)
-2%
(74)
+16%
(84)
-14%
(100)
-19%
(118)
-17%
(161)
-37%
(193)
-20%
(203)
-5%
(201)
+1%
(191)
+5%
(169)
+11%
(161)
+5%
(169)
-5%
(160)
+5%
(168)
-5%
(184)
-9%
(163)
+11%
(107)
+34%
(114)
-6%
(93)
+18%
(98)
-5%
(150)
-53%
(109)
+27%
(100)
+9%
(101)
-1%
(93)
+8%
(118)
-27%
(131)
-11%
(120)
+8%
(128)
-6%
(123)
+4%
(103)
+16%
(89)
+13%
(75)
+16%
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett